| IVITX | VVIAX | IVITX / VVIAX | |
| Total Expense Ratio | 1.04 | 0.05 | 2,080% |
| Annual Report Gross Expense Ratio | 1.04 | 0.05 | 2,080% |
| Fund Existence | 23 years | 25 years | - |
| Gain YTD | -7.884 | 10.852 | -73% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 158M | 208B | 0% |
| Annual Yield % from dividends | 0.48 | 2.09 | 23% |
| Returns for 1 year | -12.08 | 5.48 | -220% |
| Returns for 3 years | -3.27 | 32.94 | -10% |
| Returns for 5 years | 10.51 | 64.69 | 16% |
| Returns for 10 years | -7.77 | 128.99 | -6% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SHSSX | 72.42 | 0.69 | +0.96% |
| BlackRock Health Sciences Opps Instl | |||
| VFMFX | 45.84 | 0.26 | +0.57% |
| Vanguard US Multifactor Admiral™ | |||
| CSVAX | 23.03 | 0.11 | +0.48% |
| Columbia International Div Inc A | |||
| ALCBX | 13.41 | N/A | N/A |
| ALPS/Smith Balanced Opportunity C | |||
| FIJYX | 40.72 | N/A | N/A |
| Fidelity Advisor Biotechnology Z | |||